Suppr超能文献

中耳耐多药结核病:一例报告。

Multidrug-resistant tuberculosis in middle ear: A case report.

作者信息

Cao Tanze, Liu Xiuping, Yang Chengqing, Mei Chunlin, Ou Jiali, Du Ronghui

机构信息

Department of Respiratory and Critical Care Medicine, Wuhan Pulmonary Hospital, Wuhan 430030, China.

出版信息

J Clin Tuberc Other Mycobact Dis. 2023 Feb 27;31:100355. doi: 10.1016/j.jctube.2023.100355. eCollection 2023 May.

Abstract

BACKGROUND

Tuberculosis (TB) continues to be a common disease in developing countries, among which middle ear TB is rare. Furthermore, it is relatively difficult to make an early diagnosis and provide follow-up treatment for middle ear TB. So, it is necessary to report this case for reference and further discussion.

CASE PRESENTATION

We reported 1 case of multidrug-resistant tuberculosis otitis media. TB otitis media is rare in tuberculosis; multidrug-resistant TB otitis media is even more rare. Our paper analyzes the possible causes, imaging, molecular biology, pathology, and clinical manifestations of multidrug-resistant TB otitis media.

CONCLUSION

PCR and DNA molecular biology techniques are highly recommended for the early diagnosis of multidrug-resistant TB otitis media. Early, effective anti-tuberculosis treatment is the guarantee for further recovery for patients with multidrug-resistant TB otitis media.

摘要

背景

结核病在发展中国家仍然是一种常见疾病,其中中耳结核较为罕见。此外,中耳结核的早期诊断和后续治疗相对困难。因此,有必要报告此病例以供参考和进一步讨论。

病例报告

我们报告了1例耐多药结核性中耳炎病例。结核性中耳炎在结核病中较为罕见;耐多药结核性中耳炎更为罕见。我们的论文分析了耐多药结核性中耳炎的可能病因、影像学表现、分子生物学特征、病理学特征及临床表现。

结论

强烈推荐采用PCR和DNA分子生物学技术对耐多药结核性中耳炎进行早期诊断。早期、有效的抗结核治疗是耐多药结核性中耳炎患者进一步康复的保证。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a18d/10011421/d865a1abbb36/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验